 Cost-Benefit Analysis
"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
| Descriptor ID |
D003362
|
| MeSH Number(s) |
N03.219.151.125
|
| Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost Benefit- Cost Benefit
- Benefits and Costs
- Costs and Benefits
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in UAMS Profiles by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 4 | 6 | | 2023 | 0 | 5 | 5 | | 2022 | 0 | 3 | 3 | | 2021 | 0 | 6 | 6 | | 2020 | 0 | 6 | 6 | | 2019 | 5 | 9 | 14 | | 2018 | 1 | 7 | 8 | | 2017 | 4 | 2 | 6 | | 2016 | 1 | 7 | 8 | | 2015 | 1 | 13 | 14 | | 2014 | 2 | 9 | 11 | | 2013 | 0 | 6 | 6 | | 2012 | 0 | 8 | 8 | | 2011 | 1 | 11 | 12 | | 2010 | 2 | 8 | 10 | | 2009 | 0 | 8 | 8 | | 2008 | 0 | 6 | 6 | | 2007 | 0 | 5 | 5 | | 2006 | 0 | 9 | 9 | | 2005 | 0 | 8 | 8 | | 2004 | 0 | 2 | 2 | | 2003 | 0 | 7 | 7 | | 2002 | 2 | 6 | 8 | | 2001 | 0 | 1 | 1 | | 2000 | 0 | 3 | 3 | | 1999 | 0 | 2 | 2 | | 1998 | 0 | 3 | 3 | | 1997 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles over the past ten years.
-
Hansen DK, Lu X, Puglianini OC, Sorensen S, Usmani SZ, Zhang E, Huo S, Zhang Y, Qureshi ZP, Jagannath S. Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4. Front Immunol. 2024; 15:1408892.
-
Gressler LE, Marinac-Dabic D, Resnic FS, Williams S, Yang K, Weichold F, Avila-Tang E, Mack C, Coplan P, Panagiotou OA, Pappas G. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks. Ther Innov Regul Sci. 2024 Nov; 58(6):1042-1052.
-
Frost HM, Stein AB, Keith A, Jenkins TC. Cost-Effectiveness of Pediatric Conjunctivitis Management and Return to Childcare and School Strategies: A Comparative Study. J Pediatric Infect Dis Soc. 2024 Jul 20; 13(7):341-348.
-
Short E, Selig JP, Felix HC, Painter J, McElfish PA, Rowland B, Ammerman AS, Bounds K, Henske J, Hudson JS, Li J, Young SG, Long CR. Healthy food delivery for type 2 diabetes management in rural clinics' patients: A comparative effectiveness randomized controlled trial protocol. Contemp Clin Trials. 2024 05; 140:107491.
-
Kim J, Rose ML, Pierce JE, Nickels L, Copland DA, Togher L, Godecke E, Meinzer M, Rai T, Hurley M, Foster A, Carragher M, Wilcox C, Cadilhac DA. High-Intensity Aphasia Therapy Is Cost-Effective in People With Poststroke Aphasia: Evidence From the COMPARE Trial. Stroke. 2024 Mar; 55(3):705-714.
-
Parker A, Arundel C, Clark L, Coleman E, Doherty L, Hewitt CE, Beard D, Bower P, Cooper C, Culliford L, Devane D, Emsley R, Eldridge S, Galvin S, Gillies K, Montgomery A, Sutton CJ, Treweek S, Torgerson DJ. Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme. Health Technol Assess. 2024 01; 28(2):1-114.
-
Henry E, Al-Janabi H, Brouwer W, Cullinan J, Engel L, Griffin S, Hulme C, Kingkaew P, Lloyd A, Payakachat N, Pennington B, Pe?a-Longobardo LM, Prosser LA, Shah K, Ungar WJ, Wilkinson T, Wittenberg E. Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force. Pharmacoeconomics. 2024 Mar; 42(3):343-362.
-
Tilford JM, Tarlan A. The Carer QALY Trap and Altruism in Economic Evaluations. Pharmacoeconomics. 2023 Dec; 41(12):1553-1555.
-
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.
-
Borre ED, Johri M, Dubno JR, Myers ER, Emmett SD, Pavon JM, Francis HW, Ogbuoji O, Sanders Schmidler GD. Potential Clinical and Economic Outcomes of Over-the-Counter Hearing Aids in the US. JAMA Otolaryngol Head Neck Surg. 2023 07 01; 149(7):607-614.
-
McCoy HC, Allison MK, Hernandez M, Ali MM, Stokes M, Bogulski CA, Eswaran H. Assessment of Pregnancy-Related Telehealth Interventions in the United States: A 10-Year Scoping Review. Telemed J E Health. 2024 01; 30(1):36-46.
-
Lewis KN, Tilford JM, Goudie A, Beavers J, Casey PH, McKelvey LM. Cost-benefit analysis of home visiting to reduce infant mortality among preterm infants. J Pediatr Nurs. 2023 Jul-Aug; 71:e112-e119.
-
Syal G, Melmed GY, Almario CV, Spiegel BMR. Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine. Dig Dis Sci. 2023 02; 68(2):404-413.
-
Borre ED, Myers ER, Dubno JR, Emmett SD, Pavon JM, Francis HW, Ogbuoji O, Sanders Schmidler GD. Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule. JAMA Health Forum. 2022 11 04; 3(11):e224065.
-
Borre ED, Dubno JR, Myers ER, Emmett SD, Pavon JM, Francis HW, Ogbuoji O, Sanders Schmidler GD. Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA. J Gen Intern Med. 2023 03; 38(4):978-985.
-
Ortega JA, Park CH. The benefit and cost of voluntary work in government: The case of the United States Coast Guard Auxiliary Boat Crew Program. Eval Program Plann. 2022 10; 94:102121.
-
Stone RL, Cambron-Mellott MJ, Beusterien K, Maculaitis MC, Ritz S, Mulvihill E, Monberg M, Szamreta EA, Amin S, McLaurin K. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer. Future Oncol. 2022 Feb; 18(4):491-503.
-
Hummel MA, Griffin R, Arkema K, Guerry AD. Economic evaluation of sea-level rise adaptation strongly influenced by hydrodynamic feedbacks. Proc Natl Acad Sci U S A. 2021 07 20; 118(29).
-
Raley E, Jefferson AA. Reimagining Cost-Effectiveness Analyses: A Role for Social Determinants of Health? J Allergy Clin Immunol Pract. 2021 05; 9(5):1948-1949.
-
Gupta S, Zhu J, McCarty TR, Pruce J, Kassam Z, Kelly C, Fischer M, Allegretti JR. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. J Gastroenterol Hepatol. 2021 Sep; 36(9):2432-2440.
-
Moverman MA, Bruha MJ, Pagani NR, Puzzitiello RN, Menendez ME, Barnes CL. Perioperative Medical Optimization of Symptomatic Benign Prostatic Hyperplasia Is an Economically Justified Infection Prevention Strategy in Total Joint Arthroplasty. J Arthroplasty. 2021 07; 36(7):2551-2557.
-
Eigenmann PA, Ebisawa M, Greenhawt M, Hourihane JO, Perry TT, Remington BC, Wood RA. Addressing risk management difficulties in children with food allergies. Pediatr Allergy Immunol. 2021 05; 32(4):658-666.
-
Pagani NR, Moverman MA, Puzzitiello RN, Menendez ME, Barnes CL, Kavolus JJ. Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty. J Arthroplasty. 2021 02; 36(2):700-704.
-
Smith AE, Kamm GL, Lai S, Hull MJ, Baker JR, Milte R, Ratcliffe J, Loetscher T, Keage HAD. A RE-AIM Analysis of an Intergenerational Dementia Education Program. Front Public Health. 2020; 8:248.
-
Yong M, Liang J, Ballreich J, Lea J, Westerberg BD, Emmett SD. Cost-effectiveness of School Hearing Screening Programs: A Scoping Review. Otolaryngol Head Neck Surg. 2020 06; 162(6):826-838.
-
Tremblay G, Dolph M, Roy AN, Said Q, Forsythe A. The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States. Clin Ther. 2020 05; 42(5):860-872.e8.
-
Hamadeh IS, Reese ES, Arnall JR, Kachur E, Martin AL, Schneider M, Friend R, Paul B, Atrash S, Bhutani M, Voorhees PM, Usmani SZ. Safety and Cost Benefits of the Rapid Daratumumab Infusion Protocol. Clin Lymphoma Myeloma Leuk. 2020 08; 20(8):526-532.e1.
-
Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.
-
Hughes E, Mitchell N, Gascoyne S, Moe-Byrne T, Edmondson A, Coleman E, Millett L, Ali S, Dare C, Hewitt C, Johnson S, Llewellyn C, Mercer C, Nolan F, Walker C, Watson J. Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT. Health Technol Assess. 2019 12; 23(65):1-136.
-
Manz KC, Waters TM, Clifton HE, Kocak M, Klesges RC, Talcott GW, Krukowski RA. Cost-Effectiveness of a Weight Loss Intervention: An Adaptation of the Look AHEAD Lifestyle Intervention in the US Military. Obesity (Silver Spring). 2020 01; 28(1):89-96.
-
Krajcer Z, Ramaiah VG, Henao EA, Nelson WK, Moursi MM, Rajasinghe HA, Anderson LH, Miller LE. Comparison of perioperative costs with fast-track vs standard endovascular aneurysm repair. Vasc Health Risk Manag. 2019; 15:385-393.
-
Davis DR, DeSarno MJ, Bergeria CL, Streck JM, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate. Prev Med. 2019 11; 128:105823.
-
Barnett CL, Davenport MS, Montgomery JS, Kunju LP, Denton BT, Piert M. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis. J Nucl Med. 2019 12; 60(12):1705-1712.
-
Lang SM, Alsaied T, Moore RA, Rattan M, Ryan TD, Taylor MD. Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management. Int J Cardiovasc Imaging. 2019 Dec; 35(12):2213-2219.
-
Dopp AR, Mundey P, Silovsky JF, Hunter M, Slemaker A. Economic value of community-based services for problematic sexual behaviors in youth: A mixed-method cost-effectiveness analysis. Child Abuse Negl. 2020 07; 105:104043.
-
Emmett SD, Sudoko CK, Tucci DL, Gong W, Saunders JE, Akhtar N, Bhutta MF, Touch S, Pradhananga RB, Mukhtar N, Martinez N, Martinez FD, Ramos H, Kameswaran M, Kumar RNS, Soekin S, Prepageran N. Expanding Access: Cost-effectiveness of Cochlear Implantation and Deaf Education in Asia. Otolaryngol Head Neck Surg. 2019 10; 161(4):672-682.
-
Colman RE, Mace A, Seifert M, Hetzel J, Mshaiel H, Suresh A, Lemmer D, Engelthaler DM, Catanzaro DG, Young AG, Denkinger CM, Rodwell TC. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. PLoS Med. 2019 04; 16(4):e1002794.
-
Hays LH. Societal value of newborn screening for severe combined immune deficiency in Arkansas: An economic analysis. Public Health Nurs. 2019 07; 36(4):541-544.
-
Fuller CW. Assessing the Return on Investment of Injury Prevention Procedures in Professional Football. Sports Med. 2019 Apr; 49(4):621-629.
-
Wolf LL, Ejiofor JI, Wang Y, Hunink MG, Losina E, Haider AH, Smink DS. Management of Reducible Ventral Hernias: Clinical Outcomes and Cost-effectiveness of Repair at Diagnosis Versus Watchful Waiting. Ann Surg. 2019 02; 269(2):358-366.
-
Younes F, Eghbali A, De Bruyckere T, Cleymaet R, Cosyn J. A randomized controlled trial on the efficiency of free-handed, pilot-drill guided and fully guided implant surgery in partially edentulous patients. Clin Oral Implants Res. 2019 Feb; 30(2):131-138.
-
Banerjee S, Jeon-Slaughter H, Armstrong EJ, Bajzer C, Abu-Fadel M, Khalili H, Prasad A, Bou Dargham B, Kamath P, Addo T, Luna M, Gigliotti O, Foteh M, Cawich I, Kinlay S, Ali M, Ramanan B, Niazi K, Tsai S, Shammas NW, Brilakis ES. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry. J Invasive Cardiol. 2019 01; 31(1):1-9.
-
Abbas Y, Smith G, Trinidade A. Audiologist-led screening of acoustic neuromas in patients with asymmetrical sensorineural hearing loss and/or unilateral tinnitus: our experience in 1126 patients. J Laryngol Otol. 2018 Sep; 132(9):786-789.
-
Mehta S, Blagg R, Willcockson J, Gociman B, Yamashiro D, Siddiqi F. Cost-Effectiveness Analysis of Demineralized Bone Matrix and rhBMP-2 versus Autologous Iliac Crest Bone Grafting in Alveolar Cleft Patients. Plast Reconstr Surg. 2018 09; 142(3):737-743.
-
White RMB, Nair RL, Bradley RH. Theorizing the benefits and costs of adaptive cultures for development. Am Psychol. 2018 09; 73(6):727-739.
-
Klyn NAM, Kleindienst Robler S, Alfakir R, Nielsen DW, Griffith JW, Carlson DL, Lundy L, Dhar S, Zapala DA. A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample. Ear Hear. 2018 Sep-Oct; 39(5):1035-1038.
-
Bhalla V, Abdel-Latif A, Bhalla M, Ziada K, Williams MV, Smyth SS. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients. Am J Cardiol. 2018 10 01; 122(7):1236-1243.
-
Rodriguez-Araujo G, Cilingiroglu M, Mego D, Hakeem A, Lendel V, Cawich I, Paixao A, Marmagkiolis K, Flaherty P, Rollefson W. Same versus next day discharge after elective transradial PCI: The RAdial SAme Day DischArge after PCI trial. (The RASADDA-PCI trial). Cardiovasc Revasc Med. 2018 09; 19(6S):7-11.
-
Magro I, Emmett SD, Saunders J. Cost-effectiveness of CI in developing countries. Curr Opin Otolaryngol Head Neck Surg. 2018 Jun; 26(3):190-195.
-
Salgado Garc?a FI, Derefinko KJ, Bursac Z, Hand S, Klesges RC. Planning a Change Easily (PACE): A randomized controlled trial for smokers who are not ready to quit. Contemp Clin Trials. 2018 05; 68:14-22.
-
Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer. BJU Int. 2018 07; 122(1):50-58.
-
Dopp AR, Coen AS, Smith AB, Reno J, Bernstein DH, Kerns SEU, Altschul D. Economic Impact of the Statewide Implementation of an Evidence-Based Treatment: Multisystemic Therapy in New Mexico. Behav Ther. 2018 07; 49(4):551-566.
-
Bizzell JG, Richter GT, Bower CM, Woods GL, Nolder AR. Routine pathologic examination of tonsillectomy specimens: A 10-year experience at a tertiary care children's hospital. Int J Pediatr Otorhinolaryngol. 2017 Nov; 102:86-89.
-
Rajan PV, Qudsi RA, Wolf LL, Losina E. Cost-Effectiveness Analyses in Orthopaedic Surgery: Raising the Bar. J Bone Joint Surg Am. 2017 07 05; 99(13):e71.
-
Painter JT, Fortney JC, Austen MA, Pyne JM. Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder. Psychiatr Serv. 2017 Nov 01; 68(11):1157-1163.
-
Overley SC, McAnany SJ, Brochin RL, Kim JS, Merrill RK, Qureshi SA. The 5-year cost-effectiveness of two-level anterior cervical discectomy and fusion or cervical disc replacement: a Markov analysis. Spine J. 2018 01; 18(1):63-71.
-
Eswaran H, Escalona-Vargas D, Bolin EH, Wilson JD, Lowery CL. Fetal magnetocardiography using optically pumped magnetometers: a more adaptable and less expensive alternative? Prenat Diagn. 2017 Feb; 37(2):193-196.
-
Hammond DA, Kathe N, Shah A, Martin BC. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients. Pharmacotherapy. 2017 01; 37(1):43-53.
-
Drummond KL, Painter JT, Curran GM, Stanley R, Gifford AL, Rodriguez-Barradas M, Rimland D, Monson TP, Pyne JM. HIV patient and provider feedback on a telehealth collaborative care for depression intervention. AIDS Care. 2017 03; 29(3):290-298.
-
Conces MR, Arnold CA, Baker PB, Carter CM, Fung B, Prasad V, Arnold MA. A Strategy for Helicobacter Immunohistochemistry Utilization in Pediatric Practice: ?Insights From Morphologic and Cost-Benefit Analyses. Am J Clin Pathol. 2016 Nov 01; 146(5):611-617.
-
Stambough JB, Nam D, Warren DK, Keeney JA, Clohisy JC, Barrack RL, Nunley RM. Decreased Hospital Costs and Surgical Site Infection Incidence With a Universal Decolonization Protocol in Primary Total Joint Arthroplasty. J Arthroplasty. 2017 03; 32(3):728-734.e1.
-
Njei B, McCarty TR, Fortune BE, Lim JK. Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2016 11; 44(10):1090-1101.
-
Emmett SD, Tucci DL, Bento RF, Garcia JM, Juman S, Chiossone-Kerdel JA, Liu TJ, de Mu?oz PC, Ullauri A, Letort JJ, Mansilla T, Urquijo DP, Aparicio ML, Gong W, Francis HW, Saunders JE. Moving Beyond GDP: Cost Effectiveness of Cochlear Implantation and Deaf Education in Latin America. Otol Neurotol. 2016 09; 37(8):1040-8.
-
Cressman S, Karsan A, Hogge DE, McPherson E, Bolbocean C, Regier DA, Peacock SJ. Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia. Br J Haematol. 2016 08; 174(4):526-35.
-
Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61.
-
Berber E, Bernet V, Fahey TJ, Kebebew E, Shaha A, Stack BC, Stang M, Steward DL, Terris DJ. American Thyroid Association Statement on Remote-Access Thyroid Surgery. Thyroid. 2016 Mar; 26(3):331-7.
-
Balogh J, Gordon Burroughs S, Boktour M, Patel S, Saharia A, Ochoa RA, McFadden R, Victor DW, Ankoma-Sey V, Galati J, Monsour HP, Fainstein V, Li XC, Grimes KA, Gaber AO, Aloia T, Ghobrial RM. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients. Liver Transpl. 2016 Feb; 22(2):163-70.
-
Ferguson A, Yates C, Tilford JM. Value-based insurance designs in the treatment of mental health disorders. Am J Manag Care. 2016 Jan 01; 22(1):e38-44.
-
Nandi D, Lin KY, O'Connor MJ, Elci OU, Kim JJ, Decker JA, Price JF, Zafar F, Morales DL, Denfield SW, Dreyer WJ, Jefferies JL, Rossano JW. Hospital Charges for Pediatric Heart Failure-Related Hospitalizations from 2000 to 2009. Pediatr Cardiol. 2016 Mar; 37(3):512-8.
-
Painter JT, Fortney JC, Gifford AL, Rimland D, Monson T, Rodriguez-Barradas MC, Pyne JM. Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):377-85.
-
Usmani SZ, Cavenagh JD, Belch AR, Hulin C, Basu S, White D, Nooka A, Ervin-Haynes A, Yiu W, Nagarwala Y, Berger A, Pelligra CG, Guo S, Binder G, Gibson CJ, Facon T. Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma. J Med Econ. 2016; 19(3):243-58.
-
Tilford JM, Payakachat N, Kuhlthau KA, Pyne JM, Kovacs E, Bellando J, Williams DK, Brouwer WB, Frye RE. Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects. J Autism Dev Disord. 2015 Nov; 45(11):3613-23.
-
Payakachat N, Ali MM, Tilford JM. Can The EQ-5D Detect Meaningful Change? A Systematic Review. Pharmacoeconomics. 2015 Nov; 33(11):1137-54.
-
Meena N, Jeffus S, Massoll N, Siegel ER, Korourian S, Chen C, Bartter T. Rapid onsite evaluation: A comparison of cytopathologist and pulmonologist performance. Cancer Cytopathol. 2016 Apr; 124(4):279-84.
-
Reddy SM, Guannel G, Griffin R, Faries J, Boucher T, Thompson M, Brenner J, Bernhardt J, Verutes G, Wood SA, Silver JA, Toft J, Rogers A, Maas A, Guerry A, Molnar J, DiMuro JL. Evaluating the role of coastal habitats and sea-level rise in hurricane risk mitigation: An ecological economic assessment method and application to a business decision. Integr Environ Assess Manag. 2016 Apr; 12(2):328-44.
-
Emmett SD, Tucci DL, Smith M, Macharia IM, Ndegwa SN, Nakku D, Mukara KB, Kaitesi MB, Ibekwe TS, Mulwafu W, Gong W, Francis HW, Saunders JE. GDP Matters: Cost Effectiveness of Cochlear Implantation and Deaf Education in Sub-Saharan Africa. Otol Neurotol. 2015 Sep; 36(8):1357-65.
-
Sheikh A, Patel NJ, Nalluri N, Agnihotri K, Spagnola J, Patel A, Asti D, Kanotra R, Khan H, Savani C, Arora S, Patel N, Thakkar B, Patel N, Pau D, Badheka AO, Deshmukh A, Kowalski M, Viles-Gonzalez J, Paydak H. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis. 2015 Sep-Oct; 58(2):105-16.
-
Mazal JR, Ludwig R. Using mobile electronic devices to deliver educational resources in developing countries. Radiol Technol. 2015 May-Jun; 86(5):490-8.
-
Roth RM, Hampel H, Arnold CA, Yearsley MM, Marsh WL, Frankel WL. A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial. Am J Clin Pathol. 2015 Mar; 143(3):336-43.
-
Pyne JM, Fortney JC, Mouden S, Lu L, Hudson TJ, Mittal D. Cost-effectiveness of on-site versus off-site collaborative care for depression in rural FQHCs. Psychiatr Serv. 2015 May 01; 66(5):491-9.
-
Hughes DS, Ussery DJ, Woodruff DL, Sandlin AT, Kinder SR, Magann EF. The continuing antenatal management program (CAMP): Outpatient monitoring of high-risk pregnancies. Keeps patients safe, costs low and care nearby. Sex Reprod Healthc. 2015 Jun; 6(2):108-9.
-
Blake DR, Spielberg F, Levy V, Lensing S, Wolff PA, Venkatasubramanian L, Acevedo N, Padian N, Chattopadhyay I, Gaydos CA. Could home sexually transmitted infection specimen collection with e-prescription be a cost-effective strategy for clinical trials and clinical care? Sex Transm Dis. 2015 Jan; 42(1):13-9.
-
Birch SJ, Golbeck AL. The effectiveness of screening with interferon-gamma release assays in a university health care setting with a diverse global population. J Am Coll Health. 2015; 63(3):180-5.
-
Tait MA, Dredge C, Barnes CL. Preoperative Patient Education for Hip and Knee Arthroplasty: Financial Benefit? J Surg Orthop Adv. 2015; 24(4):246-51.
-
Sachdeva R. The first pediatric appropriate use criteria: a step towards providing quality care in a cost-effective manner. J Am Soc Echocardiogr. 2014 Dec; 27(12):21A-22A.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|